Cargando…

Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020

Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries. Thirty-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reusken, Chantal B.E.M., Broberg, Eeva K., Haagmans, Bart, Meijer, Adam, Corman, Victor M., Papa, Anna, Charrel, Remi, Drosten, Christian, Koopmans, Marion, Leitmeyer, Katrin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2020
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029448/ https://www.ncbi.nlm.nih.gov/pubmed/32046815 http://dx.doi.org/10.2807/1560-7917.ES.2020.25.6.2000082

Ejemplares similares

Need for additional capacity and improved capability for molecular detection of yellow fever virus in European Expert Laboratories: External Quality Assessment, March 2018
por: Domingo, Cristina, et al.
Publicado: (2018)

Upsurge in echovirus 30 detections in five EU/EEA countries, April to September, 2018
por: Broberg, Eeva K, et al.
Publicado: (2018)

Authors’ response: Plenty of coronaviruses but no SARS-CoV-2
por: Reusken, Chantal B, et al.
Publicado: (2020)

High impact of COVID-19 in long-term care facilities, suggestion for monitoring in the EU/EEA, May 2020
por: Danis, Kostas, et al.
Publicado: (2020)

Status, quality and specific needs of Zika virus (ZIKV) diagnostic capacity and capability in National Reference Laboratories for arboviruses in 30 EU/EEA countries, May 2016
por: Mögling, Ramona, et al.
Publicado: (2017)

Epidemiology of measles during the COVID-19 pandemic, a description of the surveillance data, 29 EU/EEA countries and the United Kingdom, January to May 2020
por: Nicolay, Nathalie, et al.
Publicado: (2020)

Decrease in community antibiotic consumption during the COVID-19 pandemic, EU/EEA, 2020
por: Högberg, Liselotte Diaz, et al.
Publicado: (2021)

Increasing number of cases and outbreaks caused by Candida auris in the EU/EEA, 2020 to 2021
por: Kohlenberg, Anke, et al.
Publicado: (2022)

Automated digital reporting of clinical laboratory information to national public health surveillance systems, results of a EU/EEA survey, 2018
por: Leitmeyer, Katrin Claire, et al.
Publicado: (2020)

Rebound in community antibiotic consumption after the observed decrease during the COVID-19 pandemic, EU/EEA, 2022
por: Ventura-Gabarró, Cèlia, et al.
Publicado: (2023)

Current practices for respiratory syncytial virus surveillance across the EU/EEA Member States, 2017
por: Mollers, Madelief, et al.
Publicado: (2019)

Variable Sensitivity of SARS-CoV-2 Molecular Detection in European Expert Laboratories: External Quality Assessment, June and July 2020
por: Fischer, Carlo, et al.
Publicado: (2021)

Tuberculosis notification rate decreases faster in residents of native origin than in residents of foreign origin in the EU/EEA, 2010 to 2015
por: Hollo, V, et al.
Publicado: (2017)

Surveillance of Zika virus infection in the EU/EEA, June 2015 to January 2017
por: Spiteri, G, et al.
Publicado: (2017)

Investigation of an international outbreak of multidrug-resistant monophasic Salmonella Typhimurium associated with chocolate products, EU/EEA and United Kingdom, February to April 2022
por: Larkin, Lesley, et al.
Publicado: (2022)

HIV diagnoses among people born in Ukraine reported by EU/EEA countries in 2022: impact on regional HIV trends and implications for healthcare planning
por: Reyes-Urueña, Juliana, et al.
Publicado: (2023)

Yellow fever in the diagnostics laboratory
por: Domingo, Cristina, et al.
Publicado: (2018)

Dominant influenza A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and 2017/18 seasons, respectively
por: Adlhoch, Cornelia, et al.
Publicado: (2018)

Large increase in bloodstream infections with carbapenem-resistant Acinetobacter species during the first 2 years of the COVID-19 pandemic, EU/EEA, 2020 and 2021
por: Kinross, Pete, et al.
Publicado: (2022)

Novel coronavirus (2019-nCoV) early-stage importation risk to Europe, January 2020
por: Pullano, Giulia, et al.
Publicado: (2020)

Toscana, West Nile, Usutu and tick-borne encephalitis viruses: external quality assessment for molecular detection of emerging neurotropic viruses in Europe, 2017
por: Reusken, Chantal, et al.
Publicado: (2019)

Initial assessment of the COVID-19 vaccination’s impact on case numbers, hospitalisations and deaths in people aged 80 years and older, 15 EU/EEA countries, December 2020 to May 2021
por: Nicolay, Nathalie, et al.
Publicado: (2021)

International external quality assessment for SARS-CoV-2 molecular detection and survey on clinical laboratory preparedness during the COVID-19 pandemic, April/May 2020
por: Matheeussen, Veerle, et al.
Publicado: (2020)

Candida auris: epidemiological situation, laboratory capacity and preparedness in the European Union and European Economic Area*, January 2018 to May 2019
por: Plachouras, Diamantis, et al.
Publicado: (2020)

Is EU/EEA population protected from polio?
por: Nijsten, DRE, et al.
Publicado: (2015)

Monitoring of HIV testing services in the EU/EEA
por: Tavoschi, Lara, et al.
Publicado: (2016)

Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020
por: Riou, Julien, et al.
Publicado: (2020)

Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022
por: Sentís, Alexis, et al.
Publicado: (2022)

Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021
por: Funk, Tjede, et al.
Publicado: (2021)

Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022
por: Eggink, Dirk, et al.
Publicado: (2022)

Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020
por: Backer, Jantien A, et al.
Publicado: (2020)

Reply: Tuberculosis screening in migrants to the EU/EEA and UK
por: Zenner, Dominik, et al.
Publicado: (2023)

MERS coronavirus: Data gaps for laboratory preparedness
por: de Sousa, Rita, et al.
Publicado: (2014)

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
por: Corman, Victor M, et al.
Publicado: (2020)

Delayed Laboratory Response to COVID-19 Caused by Molecular Diagnostic Contamination
por: Mögling, Ramona, et al.
Publicado: (2020)

External quality assessment of SARS-CoV-2 serology in European expert laboratories, April 2021
por: Mögling, Ramona, et al.
Publicado: (2022)

Cross host transmission in the emergence of MERS coronavirus
por: Reusken, Chantal BEM, et al.
Publicado: (2016)

Specialist laboratory networks as preparedness and response tool - the Emerging Viral Diseases-Expert Laboratory Network and the Chikungunya outbreak, Thailand, 2019
por: Venturi, Giulietta, et al.
Publicado: (2020)

Legionnaires’ disease in the EU/EEA*: increasing trend from 2017 to 2019
por: Samuelsson, Jonas, et al.
Publicado: (2023)

Spatiotemporal spread of tick-borne encephalitis in the EU/EEA, 2012 to 2020
por: Van Heuverswyn, Jasper, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t7g8l55a9r2n10f3slk24b1unm